Supreme Court Won't Mull Hospira's Duty To Supply Drug

Law360, New York (October 15, 2013, 5:55 PM EDT) -- The U.S. Supreme Court on Tuesday declined to review the Eleventh Circuit's ruling that Hospira Inc. had no special duty to a proposed class of patients to supply an injectable form of vitamin A, even if it was the drug's only manufacturer.

The high court denied a petition for certiorari filed in September by Jennifer Lacognata, who claims she needs the drug Aquasol A because she cannot metabolize the vitamin A content in her food. Hospira is the only company approved to sell injectable vitamin A...
To view the full article, register now.